Current portfolio

Innovative Molecules

Re-Inventing treatment of herpes infections.

  • Sector
    Healthcare
  • Country
    Germany
  • Fund
    LSP 6
  • Entry
    2021
Logo

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180